O	O	O	0	7	Effects	Effect	B-NP	NNS	O	0	ROOT	O
O	O	O	8	10	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	11	16	alpha	alpha	B-NP	SYM	O	6	NMOD	O
O	O	O	16	17	-	-	O	HYPH	O	6	NMOD	O
O	O	O	17	23	lipoic	lipoic	B-NP	JJ	O	6	NMOD	O
O	O	O	24	28	acid	acid	I-NP	NN	O	9	NMOD	O
O	O	O	29	32	and	and	O	CC	O	9	NMOD	O
O	O	O	33	46	dihydrolipoic	dihydrolipoic	B-NP	JJ	O	9	NMOD	O
O	O	O	47	51	acid	acid	I-NP	NN	O	2	PMOD	O
O	O	O	52	54	on	on	B-PP	IN	O	1	NMOD	O
O	O	O	55	65	expression	expression	B-NP	NN	O	10	PMOD	O
O	O	O	66	68	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	69	74	proto	proto	B-NP	AFX	B-DNA	18	NMOD	B-DNA
O	O	O	74	75	-	-	I-NP	HYPH	I-DNA	18	NMOD	I-DNA
O	O	O	75	83	oncogene	oncogene	B-NP	NN	I-DNA	18	NMOD	I-DNA
T1	B-Protein	B-Protein	84	85	c	c	I-NP	NN	I-DNA	18	NMOD	I-DNA
T1	I-Protein	I-Protein	85	86	-	-	O	:	I-DNA	18	P	I-DNA
T1	I-Protein	I-Protein	86	89	fos	fos	B-NP	NN	I-DNA	12	PMOD	I-DNA
O	O	O	89	90	.	.	O	.	O	1	P	O

O	O	O	92	95	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	96	109	transcription	transcription	I-NP	NN	B-protein	3	NMOD	B-protein
O	O	O	110	116	factor	factor	I-NP	NN	I-protein	5	NMOD	I-protein
T9	B-Entity	B-Entity	117	119	AP	AP	I-NP	NN	B-protein	5	NMOD	B-protein
T9	I-Entity	I-Entity	119	120	-	-	B-NP	HYPH	I-protein	7	SUB	I-protein
T9	I-Entity	I-Entity	120	121	1	1	I-NP	CD	I-protein	5	NMOD	I-protein
O	O	O	122	124	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	125	127	an	an	B-NP	DT	O	11	NMOD	O
O	O	O	128	137	important	important	I-NP	JJ	O	10	AMOD	O
O	O	O	138	143	human	human	I-NP	JJ	O	11	NMOD	O
O	O	O	144	152	mediator	mediator	I-NP	NN	O	24	NMOD	O
O	O	O	153	155	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	156	159	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	160	168	cellular	cellular	I-NP	JJ	O	15	NMOD	O
O	O	O	169	177	response	response	I-NP	NN	O	12	PMOD	O
O	O	O	178	180	to	to	B-PP	TO	O	15	NMOD	O
O	O	O	181	186	serum	serum	B-NP	NN	O	16	PMOD	O
O	O	O	186	187	,	,	O	,	O	24	P	O
O	O	O	188	194	growth	growth	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	195	202	factors	factor	I-NP	NNS	I-protein	24	NMOD	I-protein
O	O	O	202	203	,	,	O	,	O	24	P	O
O	O	O	204	207	and	and	O	CC	O	24	NMOD	O
O	O	O	208	215	phorbol	phorbol	B-NP	NN	O	24	NMOD	O
O	O	O	216	222	esters	ester	I-NP	NNS	O	7	PRD	O
O	O	O	223	227	such	such	B-PP	JJ	O	26	PMOD	O
O	O	O	228	230	as	as	I-PP	IN	O	24	NMOD	O
O	O	O	231	233	12	12	B-NP	CD	O	36	NMOD	O
O	O	O	233	234	-	-	I-NP	HYPH	O	36	NMOD	O
O	O	O	234	235	O	O	I-NP	NN	O	36	NMOD	O
O	O	O	235	236	-	-	O	HYPH	O	36	NMOD	O
O	O	O	236	249	tetradecanoyl	tetradecanoyl	B-NP	NN	O	36	NMOD	O
O	O	O	249	250	-	-	B-NP	HYPH	O	36	NMOD	O
O	O	O	250	257	phorbol	phorbol	I-NP	NN	O	36	NMOD	O
O	O	O	257	258	-	-	O	HYPH	O	36	NMOD	O
O	O	O	258	260	13	13	B-NP	CD	O	36	NMOD	O
O	O	O	261	268	acetate	acetate	I-NP	NN	O	26	PMOD	O
O	O	O	269	270	(	(	O	(	O	39	DEP	O
O	O	O	270	273	TPA	TPA	B-NP	NN	O	39	DEP	O
O	O	O	273	274	)	)	O	)	O	36	NMOD	O
O	O	O	274	275	.	.	O	.	O	7	P	O

O	O	O	276	279	The	The	B-NP	DT	O	5	NMOD	O
T10	B-Entity	B-Entity	280	282	AP	AP	I-NP	NN	B-protein	5	NMOD	B-protein
T10	I-Entity	I-Entity	282	283	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
T10	I-Entity	I-Entity	283	284	1	1	I-NP	CD	I-protein	5	NMOD	I-protein
T10	I-Entity	I-Entity	285	292	complex	complex	I-NP	NN	I-protein	6	SUB	I-protein
O	O	O	293	301	consists	consist	B-VP	VBZ	O	0	ROOT	O
O	O	O	302	304	of	of	B-PP	IN	O	6	VMOD	O
O	O	O	305	313	distinct	distinct	B-NP	JJ	O	10	NMOD	O
T11	B-Entity	B-Entity	314	321	protein	protein	I-NP	NN	B-protein	10	NMOD	B-protein
T11	I-Entity	I-Entity	322	334	heterodimers	heterodimer	I-NP	NNS	I-protein	7	PMOD	I-protein
O	O	O	335	342	encoded	encode	B-VP	VBN	O	10	NMOD	O
O	O	O	343	345	by	by	B-PP	IN	O	11	VMOD	O
O	O	O	346	349	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	350	355	proto	proto	I-NP	AFX	B-DNA	19	NMOD	B-DNA
O	O	O	355	356	-	-	I-NP	HYPH	I-DNA	19	NMOD	I-DNA
O	O	O	356	364	oncogene	oncogene	I-NP	NN	I-DNA	19	NMOD	I-DNA
T2	B-Protein	B-Protein	365	366	c	c	I-NP	NN	I-DNA	19	NMOD	I-DNA
T2	I-Protein	I-Protein	366	367	-	-	B-NP	HYPH	I-DNA	19	NMOD	I-DNA
T2	I-Protein	I-Protein	367	370	fos	fos	I-NP	NN	I-DNA	24	NMOD	I-DNA
O	O	O	371	374	and	and	I-NP	CC	O	24	NMOD	O
T3	B-Protein	B-Protein	375	376	c	c	I-NP	NN	O	24	NMOD	O
T3	I-Protein	I-Protein	376	377	-	-	O	HYPH	O	24	NMOD	O
T3	I-Protein	I-Protein	377	380	jun	jun	B-NP	NN	B-RNA	24	NMOD	B-RNA
O	O	O	381	385	mRNA	mRNA	I-NP	NN	I-RNA	27	NMOD	I-RNA
O	O	O	386	391	whose	whose	B-NP	WP$	O	27	NMOD	O
O	O	O	392	396	gene	gene	I-NP	NN	O	27	NMOD	O
O	O	O	397	407	expression	expression	I-NP	NN	O	12	PMOD	O
O	O	O	408	411	can	can	B-VP	MD	O	6	VMOD	O
O	O	O	412	414	be	be	I-VP	VB	O	28	VC	O
O	O	O	415	422	induced	induce	I-VP	VBN	O	29	VC	O
O	O	O	423	425	by	by	B-PP	IN	O	30	VMOD	O
O	O	O	426	429	TPA	TPA	B-NP	NN	O	38	NMOD	O
O	O	O	429	430	,	,	O	,	O	38	P	O
T12	B-Entity	B-Entity	431	437	cyclic	cyclic	B-NP	JJ	O	35	NMOD	O
T12	I-Entity	I-Entity	438	441	AMP	AMP	I-NP	NN	O	38	NMOD	O
O	O	O	442	445	and	and	I-NP	CC	O	38	NMOD	O
O	O	O	446	452	growth	growth	I-NP	NN	B-protein	38	NMOD	B-protein
O	O	O	453	460	factors	factor	I-NP	NNS	I-protein	31	PMOD	I-protein
O	O	O	460	461	.	.	O	.	O	6	P	O

O	O	O	462	468	Recent	Recent	B-NP	JJ	O	2	NMOD	O
O	O	O	469	477	findings	finding	I-NP	NNS	O	3	SUB	O
O	O	O	478	485	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	486	488	an	an	B-NP	DT	O	5	NMOD	O
O	O	O	489	500	involvement	involvement	I-NP	NN	O	3	OBJ	O
O	O	O	501	503	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	504	512	reactive	reactive	B-NP	JJ	O	9	NMOD	O
O	O	O	513	519	oxygen	oxygen	I-NP	NN	O	9	NMOD	O
O	O	O	520	527	species	specie	I-NP	NNS	O	6	PMOD	O
O	O	O	528	530	in	in	B-PP	IN	O	5	NMOD	O
O	O	O	531	534	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	535	542	pathway	pathway	I-NP	NN	O	10	PMOD	O
O	O	O	543	545	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	546	549	TPA	TPA	B-NP	NN	O	18	NMOD	O
O	O	O	550	553	and	and	I-NP	CC	O	18	NMOD	O
O	O	O	554	561	protein	protein	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	562	568	kinase	kinase	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	O	569	570	C	C	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	O	571	578	leading	lead	B-VP	VBG	O	12	NMOD	O
O	O	O	579	581	to	to	B-PP	TO	O	19	VMOD	O
O	O	O	582	592	expression	expression	B-NP	NN	O	20	PMOD	O
O	O	O	593	595	of	of	B-PP	IN	O	21	NMOD	O
T4	B-Protein	B-Protein	596	597	c	c	B-NP	NN	B-DNA	25	NMOD	B-DNA
T4	I-Protein	I-Protein	597	598	-	-	I-NP	HYPH	I-DNA	25	NMOD	I-DNA
T4	I-Protein	I-Protein	598	601	fos	fos	I-NP	NN	I-DNA	30	NMOD	I-DNA
O	O	O	602	605	and	and	I-NP	CC	O	30	NMOD	O
T5	B-Protein	B-Protein	606	607	c	c	I-NP	NN	O	30	NMOD	O
T5	I-Protein	I-Protein	607	608	-	-	O	HYPH	O	30	NMOD	O
T5	I-Protein	I-Protein	608	611	jun	jun	B-NP	NN	B-RNA	30	NMOD	B-RNA
O	O	O	612	616	mRNA	mRNA	I-NP	NN	I-RNA	22	PMOD	I-RNA
O	O	O	616	617	.	.	O	.	O	3	P	O

O	O	O	618	620	To	To	B-VP	TO	O	2	VMOD	O
O	O	O	621	632	investigate	investigate	I-VP	VB	O	10	VMOD	O
O	O	O	633	636	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	637	641	role	role	I-NP	NN	O	2	OBJ	O
O	O	O	642	644	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	645	653	reactive	reactive	B-NP	JJ	O	8	NMOD	O
O	O	O	654	660	oxygen	oxygen	I-NP	NN	O	8	NMOD	O
O	O	O	661	668	species	specie	I-NP	NNS	O	5	PMOD	O
O	O	O	669	671	we	we	B-NP	PRP	O	10	SUB	O
O	O	O	672	679	studied	study	B-VP	VBD	O	0	ROOT	O
O	O	O	680	683	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	684	691	effects	effect	I-NP	NNS	O	10	OBJ	O
O	O	O	692	694	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	695	700	alpha	alpha	B-NP	SYM	O	17	NMOD	O
O	O	O	700	701	-	-	B-NP	HYPH	O	17	NMOD	O
O	O	O	701	707	lipoic	lipoic	I-NP	JJ	O	17	NMOD	O
O	O	O	708	712	acid	acid	I-NP	NN	O	20	NMOD	O
O	O	O	713	716	and	and	O	CC	O	20	NMOD	O
O	O	O	717	730	dihydrolipoic	dihydrolipoic	B-NP	JJ	O	20	NMOD	O
O	O	O	731	735	acid	acid	I-NP	NN	O	13	PMOD	O
O	O	O	736	737	(	(	O	(	O	25	DEP	O
O	O	O	737	744	natural	natural	B-NP	JJ	O	24	NMOD	O
O	O	O	745	750	thiol	thiol	I-NP	NN	O	24	NMOD	O
O	O	O	751	763	antioxidants	antioxidant	I-NP	NNS	O	25	DEP	O
O	O	O	763	764	)	)	O	)	O	20	NMOD	O
O	O	O	765	767	on	on	B-PP	IN	O	12	NMOD	O
O	O	O	768	771	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	772	782	expression	expression	I-NP	NN	O	26	PMOD	O
O	O	O	783	785	of	of	B-PP	IN	O	28	NMOD	O
T6	B-Protein	B-Protein	786	787	c	c	B-NP	NN	B-RNA	33	NMOD	B-RNA
T6	I-Protein	I-Protein	787	788	-	-	O	HYPH	I-RNA	33	NMOD	I-RNA
T6	I-Protein	I-Protein	788	791	fos	fos	B-NP	NN	I-RNA	33	NMOD	I-RNA
O	O	O	792	796	mRNA	mRNA	I-NP	NN	I-RNA	29	PMOD	I-RNA
O	O	O	797	799	in	in	B-PP	IN	O	28	NMOD	O
O	O	O	800	805	human	human	B-NP	JJ	B-cell_line	38	NMOD	B-cell_line
O	O	O	806	812	Jurkat	Jurkat	I-NP	NN	I-cell_line	38	NMOD	I-cell_line
O	O	O	813	814	T	T	I-NP	NN	I-cell_line	38	NMOD	I-cell_line
O	O	O	815	820	cells	cell	I-NP	NNS	I-cell_line	34	PMOD	I-cell_line
O	O	O	820	821	.	.	O	.	O	10	P	O

O	O	O	822	826	When	When	B-ADVP	WRB	O	21	VMOD	O
O	O	O	827	832	cells	cell	B-NP	NNS	O	3	SUB	O
O	O	O	833	837	were	be	B-VP	VBD	O	1	SBAR	O
O	O	O	838	850	preincubated	preincubate	I-VP	VBN	O	3	VC	O
O	O	O	851	855	with	with	B-PP	IN	O	4	VMOD	O
O	O	O	856	869	dihydrolipoic	dihydrolipoic	B-NP	JJ	O	7	NMOD	O
O	O	O	870	874	acid	acid	I-NP	NN	O	5	PMOD	O
O	O	O	875	876	(	(	O	(	O	13	DEP	O
O	O	O	876	877	0	0	B-NP	CD	O	13	DEP	O
O	O	O	877	878	.	.	O	.	O	13	P	O
O	O	O	878	879	2	2	B-NP	CD	O	12	NMOD	O
O	O	O	880	882	mM	mM	I-NP	NN	O	13	DEP	O
O	O	O	882	883	)	)	O	)	O	7	NMOD	O
O	O	O	884	887	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	888	898	expression	expression	I-NP	NN	O	21	SUB	O
O	O	O	899	901	of	of	B-PP	IN	O	15	NMOD	O
T7	B-Protein	B-Protein	902	903	c	c	B-NP	NN	B-RNA	20	NMOD	B-RNA
T7	I-Protein	I-Protein	903	904	-	-	O	HYPH	I-RNA	20	NMOD	I-RNA
T7	I-Protein	I-Protein	904	907	fos	fos	B-NP	NN	I-RNA	20	NMOD	I-RNA
O	O	O	908	912	mRNA	mRNA	I-NP	NN	I-RNA	16	PMOD	I-RNA
O	O	O	913	916	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	917	927	suppressed	suppress	I-VP	VBN	O	21	VC	O
O	O	O	928	930	at	at	B-PP	IN	O	22	VMOD	O
O	O	O	931	933	30	30	B-NP	CD	O	25	NMOD	O
O	O	O	934	937	min	min	I-NP	NN	O	23	PMOD	O
O	O	O	938	943	after	after	B-PP	IN	O	25	NMOD	O
O	O	O	944	955	stimulation	stimulation	B-NP	NN	O	26	PMOD	O
O	O	O	956	958	of	of	B-PP	IN	O	27	NMOD	O
O	O	O	959	962	TPA	TPA	B-NP	NN	O	28	PMOD	O
O	O	O	963	964	(	(	O	(	O	35	DEP	O
O	O	O	964	965	0	0	B-NP	CD	O	34	NMOD	O
O	O	O	965	966	.	.	O	.	O	34	NMOD	O
O	O	O	966	967	5	5	B-NP	CD	O	34	NMOD	O
O	O	O	968	974	microM	microM	I-NP	NN	O	35	DEP	O
O	O	O	974	975	)	)	O	)	O	29	NMOD	O
O	O	O	976	983	whereas	whereas	B-PP	IN	O	21	VMOD	O
O	O	O	984	986	in	in	B-PP	IN	O	36	PMOD	O
O	O	O	987	990	the	the	B-NP	DT	O	39	NMOD	O
O	O	O	991	995	case	case	I-NP	NN	O	37	PMOD	O
O	O	O	996	998	of	of	B-PP	IN	O	39	NMOD	O
O	O	O	999	1012	preincubation	preincubation	B-NP	NN	O	40	PMOD	O
O	O	O	1013	1015	of	of	B-PP	IN	O	41	NMOD	O
O	O	O	1016	1021	alpha	alpha	B-NP	SYM	O	46	NMOD	O
O	O	O	1021	1022	-	-	O	HYPH	O	46	NMOD	O
O	O	O	1022	1028	lipoic	lipoic	B-NP	JJ	O	46	NMOD	O
O	O	O	1029	1033	acid	acid	I-NP	NN	O	55	NMOD	O
O	O	O	1034	1035	(	(	O	(	O	52	DEP	O
O	O	O	1035	1036	0	0	B-NP	CD	O	51	NMOD	O
O	O	O	1036	1037	.	.	O	.	O	51	NMOD	O
O	O	O	1037	1038	2	2	B-NP	CD	O	51	NMOD	O
O	O	O	1039	1045	microM	microM	I-NP	NN	O	52	DEP	O
O	O	O	1045	1046	)	)	O	)	O	46	NMOD	O
O	O	O	1046	1047	,	,	O	,	O	55	P	O
O	O	O	1048	1051	the	the	B-NP	DT	O	55	NMOD	O
O	O	O	1052	1062	expression	expression	I-NP	NN	O	42	PMOD	O
O	O	O	1063	1066	was	be	B-VP	VBD	O	37	SBAR	O
O	O	O	1067	1075	enhanced	enhance	I-VP	VBN	O	56	VC	O
O	O	O	1076	1078	at	at	B-PP	IN	O	57	VMOD	O
O	O	O	1079	1081	30	30	B-NP	CD	O	60	NMOD	O
O	O	O	1082	1085	min	min	I-NP	NN	O	58	PMOD	O
O	O	O	1085	1086	.	.	O	.	O	21	P	O

O	O	O	1087	1092	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1093	1100	studies	study	I-NP	NNS	O	3	SUB	O
O	O	O	1101	1108	support	support	B-VP	VBP	O	0	ROOT	O
O	O	O	1109	1112	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	1113	1117	idea	idea	I-NP	NN	O	3	OBJ	O
O	O	O	1118	1122	that	that	B-SBAR	IN	O	5	NMOD	O
O	O	O	1123	1133	superoxide	superoxide	B-NP	NN	O	9	NMOD	O
O	O	O	1134	1139	anion	anion	I-NP	NN	O	9	NMOD	O
O	O	O	1140	1147	radical	radical	I-NP	NN	O	10	SUB	O
O	O	O	1148	1153	plays	play	B-VP	VBZ	O	6	SBAR	O
O	O	O	1154	1155	a	a	B-NP	DT	O	12	NMOD	O
O	O	O	1156	1160	role	role	I-NP	NN	O	10	OBJ	O
O	O	O	1161	1163	in	in	B-PP	IN	O	10	VMOD	O
O	O	O	1164	1167	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	1168	1178	expression	expression	I-NP	NN	O	13	PMOD	O
O	O	O	1179	1181	of	of	B-PP	IN	O	15	NMOD	O
T8	B-Protein	B-Protein	1182	1183	c	c	B-NP	NN	B-RNA	20	NMOD	B-RNA
T8	I-Protein	I-Protein	1183	1184	-	-	B-NP	HYPH	I-RNA	20	NMOD	I-RNA
T8	I-Protein	I-Protein	1184	1187	fos	fos	I-NP	NN	I-RNA	20	NMOD	I-RNA
O	O	O	1188	1192	mRNA	mRNA	I-NP	NN	I-RNA	16	PMOD	I-RNA
O	O	O	1192	1193	.	.	O	.	O	3	P	O
